evidenceId,evidenceType,shortDesc,desc,id,lastEdit,status,gene/entrezGeneId,gene/hugoSymbol,gene/name,gene/oncogene,gene/curatedIsoform,gene/curatedRefSeq,gene/geneAliases/0,gene/geneAliases/1,gene/tsg,articles/0/pmid,articles/0/title,articles/0/journal,articles/0/pubDate,articles/0/volume,articles/0/issue,articles/0/pages,articles/0/authors,articles/0/elocationId,articles/0/link,articles/0/reference,articles/0/abstract,articles/1/pmid,articles/1/title,articles/1/journal,articles/1/pubDate,articles/1/volume,articles/1/issue,articles/1/pages,articles/1/authors,articles/1/elocationId,articles/1/link,articles/1/reference,articles/1/abstract,articles/2/pmid,articles/2/title,articles/2/journal,articles/2/pubDate,articles/2/volume,articles/2/issue,articles/2/pages,articles/2/authors,articles/2/elocationId,articles/2/link,articles/2/reference,articles/2/abstract,articles/3/pmid,articles/3/title,articles/3/journal,articles/3/pubDate,articles/3/volume,articles/3/issue,articles/3/pages,articles/3/authors,articles/3/elocationId,articles/3/link,articles/3/reference,articles/3/abstract,articles/4/pmid,articles/4/title,articles/4/journal,articles/4/pubDate,articles/4/volume,articles/4/issue,articles/4/pages,articles/4/authors,articles/4/elocationId,articles/4/link,articles/4/reference,articles/4/abstract,articles/5/pmid,articles/5/title,articles/5/journal,articles/5/pubDate,articles/5/volume,articles/5/issue,articles/5/pages,articles/5/authors,articles/5/elocationId,articles/5/link,articles/5/reference,articles/5/abstract
6026,GENE_BACKGROUND,,"ASXL1 is a member of the Polycomb group of proteins, and is a chromatin binder that is involved in transcription regulation. ASXL1 is a member of the ASXL gene family that includes ASXL1, ASXL2 and ASXL3, which all have a C-terminal plant homology domain (PHD domain) that is predicted to recognize histone H3 tails via methylated lysines (PMID: 23147254). ASXL1 interacts directly with the Polycomb Repressive Complex 2 (PRC2) and has a role in the recruitment of PRC2 to chromatin and subsequent H3K27me3 histone modifications (PMID: 22897849). Mutations in ASXL1 result in the inability of Polycomb target genes to be effectively repressed leading to dysregulated gene expression, such as at the HOXA gene cluster (PMID: 22897849). ASXL1 also independently interacts with the chromatin protein BAP1 (PMID: 22878500). The BAP1-ASXL1 complex can regulate the H2AK119 ubiquitin mark placed by the Polycomb Repressive Complex 1 (PRC1) (PMID: 20436459). Germline heterozygous mutations in ASXL1 have been found in patients with Bohring-Opitz syndrome, a developmental disorder that results in distinctive craniofacial abnormalities (PMID: 21706002). Recurrent somatic ASXL1 loss-of-function mutations are very common in hematopoietic malignancies including myelodysplastic syndromes (MDS), chronic myelomonocytic leukemia (CMML), myelofibrosis (MF), and acute myeloid leukemia (AML) (PMID: 23147254). Furthermore, ASXL1 mutations frequently co-occur with N/K-Ras mutations in CMML to promote leukemogenesis (PMID: 21455215).",,2017-10-18,,171023,ASXL1,"additional sex combs like 1, transcriptional regulator",False,ENST00000375687,NM_015338.5,MDS,BOPS,True,22897849,ASXL1 mutations promote myeloid transformation through loss of PRC2-mediated gene repression.,Cancer cell,2018-08-14T20:12:00,22,2,180-93,Abdel-Wahab O et al,doi: 10.1016/j.ccr.2012.06.032,,0001-08-14,,22878500,Loss of the tumor suppressor BAP1 causes myeloid transformation.,"Science (New York, N.Y.)",2018-09-21T20:12:00,337,6101,1541-6,Dey A et al,,,0001-09-21,,20436459,Histone H2A deubiquitinase activity of the Polycomb repressive complex PR-DUB.,Nature,2018-05-13T20:10:00,465,7295,243-7,Scheuermann JC et al,doi: 10.1038/nature08966,,0001-05-13,,21706002,De novo nonsense mutations in ASXL1 cause Bohring-Opitz syndrome.,Nature genetics,2018-06-26T20:11:00,43,8,729-31,Hoischen A et al,doi: 10.1038/ng.868,,0001-06-26,,21455215,"Concomitant analysis of EZH2 and ASXL1 mutations in myelofibrosis, chronic myelomonocytic leukemia and blast-phase myeloproliferative neoplasms.",Leukemia,2018-07-01T20:11:00,25,7,1200-2,Abdel-Wahab O et al,doi: 10.1038/leu.2011.58,,0001-07-01,,23147254,"The ASXL-BAP1 axis: new factors in myelopoiesis, cancer and epigenetics.",Leukemia,2018-01-01T20:13:00,27,True,2001-10-05,Abdel-Wahab O et al,doi: 10.1038/leu.2012.288,,0001-01-01,
6025,GENE_SUMMARY,,"ASXL1, a tumor suppressor and epigenetic regulator, is inactivated by mutation in various cancers, most frequently in myeloid malignancies.",,2017-10-23,,171023,ASXL1,"additional sex combs like 1, transcriptional regulator",False,ENST00000375687,NM_015338.5,MDS,BOPS,True,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
